Overview of recall records associated with AstraZeneca Pharmaceuticals, LP, including dates, categories and classifications where available.
Classification mix: Class II: 3, Class III: 1, Class I: 1.
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the…
Defective Delivery System: Some units have actuation counters set to a number other than 60.
Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM capsules contained 60 SEROQUEL XR tablets.
Presence of Precipitate; potential for incomplete constitution upon addition of diluent.
This page summarizes recall records in which the official source identifies AstraZeneca Pharmaceuticals, LP as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.
